Showing results (21-30 of 170) with videos related to
Sort By:
Pageof 17
Virologica Sinica|February 7, 2013
Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay systemJennifer Tisoncik-Go, Katie S Cordero, Lijun RongThe Journal of Biological Chemistry|March 2, 2006
Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion stateSusanna Hakansson-McReynolds, Shaokai Jiang, Lijun Rong, et al.Journal of Medical Virology|January 5, 2024
Paving new roads toward the advancement of broad-spectrum antiviral agentsRuikun Du, Jazmin G Achi, Qinghua Cui, et al.Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Small Molecule Inhibitors of Influenza Virus EntryZhaoyu Chen, Qinghua Cui, Michael Caffrey, et al.Journal of Medical Virology|January 21, 2021
Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19Varada Anirudhan, Hyun Lee, Han Cheng, et al.Cell Insight|February 19, 2025
Cedar virus biology and its applications as a surrogate for highly pathogenic henipavirusesAhmad Jawad Sabir, Lijun Rong, Christopher C Broder, et al.Virology Journal|March 22, 2008
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 bindingKatharina B Rothwangl, Balaji Manicassamy, Susan L Uprichard, et al.Protein Science : a Publication of the Protein Society|May 26, 2007
The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160Jayita Sen, Amy Jacobs, Haiqing Jiang, et al.Journal of Medical Virology|July 8, 2020
RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic targetYanyan Wang, Varada Anirudhan, Ruikun Du, et al.Journal of Medical Virology|November 6, 2023
Influenza virus cell entry and targeted antiviral developmentMurong Zhu, Varada Anirudhan, Ruikun Du, et al.Pageof 17